Evidence map›Paper›PMID 41701314›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026

DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.

Sören Schnellhardt, Simon Böke, Silke Tribius, Mechthild Krause, Marlen Haderlein, Alexander Rühle, Christoph Süß, Annett Linge, Markus Hecht, Panagiotis Balermpas and 1 more

Erratum issuedAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sören SchnellhardtDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Gebäude 6.5, Kirrberger Straße, 66421, Homburg, Germany. soeren.schnellhardt@uks.eu.ORCID http://orcid.org/0000-0003-0418-4401
Simon BökeDepartment of Radiation Oncology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
Silke TribiusDepartment of Radiation Oncology, Asklepios Klinik St.Georg, Hamburg, Germany.
Mechthild KrauseDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University, Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Marlen HaderleinDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Alexander RühleDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.
Christoph SüßDepartment of Radiotherapy, Hospital of the University of Regensburg, Regensburg, Germany.
Annett LingeDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University, Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Markus HechtDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Gebäude 6.5, Kirrberger Straße, 66421, Homburg, Germany.
Panagiotis BalermpasDepartment of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Head and Neck Cancer Expert Panel of the German Society of Radiation Oncology DEGRO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41701314
PMCPMC12999596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.